UK study digs into CMV infection patterns in kidney transplant patients
NCT ID NCT06568055
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed medical records of 330 kidney transplant patients in the UK to understand how cytomegalovirus (CMV) infections are managed. Researchers looked at how common these infections are, what treatments were used, and how well they worked. The goal was to gather information to improve future care, without changing any patient's treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RaDaR (part of the UK Kidney Association)
Bristol, Southwestern England, United Kingdom